Publicaciones en las que colabora con Francisco Javier López González (8)

2020

  1. Observational multicentre study into the use of antiepileptic drugs in Spanish neurology consultations

    Neurologia, Vol. 35, Núm. 2, pp. 115-125

2019

  1. BRIVA-LIFE–A multicenter retrospective study of the long-term use of brivaracetam in clinical practice

    Acta Neurologica Scandinavica, Vol. 139, Núm. 4, pp. 360-368

  2. Clinical outcomes of eslicarbazepine acetate monotherapy for focal-onset seizures: A multicenter audit

    Acta Neurologica Scandinavica, Vol. 140, Núm. 6, pp. 422-428

2018

  1. Perampanel in routine clinical use in idiopathic generalized epilepsy: The 12-month GENERAL study

    Epilepsia, Vol. 59, Núm. 9, pp. 1740-1752

2017

  1. EARLY-ESLI study: Long-term experience with eslicarbazepine acetate after first monotherapy failure

    Acta Neurologica Scandinavica, Vol. 136, Núm. 3, pp. 254-264

  2. Erratum to “Safety, efficacy and outcome-related factors of perampanel over 12months in a real-world setting: The FYDATA study” [Epilepsy Res. (2016) 126 (201–210)] (S0920121116301218)(10.1016/j.eplepsyres.2016.08.001)

    Epilepsy Research

2016

  1. Safety, efficacy and outcome-related factors of perampanel over 12 months in a real-world setting: The FYDATA study

    Epilepsy Research, Vol. 126, pp. 201-210

2015

  1. Early Add-on Lacosamide in a Real-Life Setting: Results of the REALLY Study

    Clinical Drug Investigation, Vol. 35, Núm. 2, pp. 121-131